.Home   Medical   Education   Tourism   Gem 'n' Jewellery    Wedding   Directory       


 
          Drug Update...
 

Aids


In the ongoing fight against AIDS, two new compounds were launched last year. The nucleoside reverse transcriptase inhibitor (NRTI)- abacavir sulfate is the first NRTI to be useful in combination with other nucleoside analogues, raising the possibility of triple nucleoside therapy. Amprenavir is the latest protease inhibitor, administered twice a day, and has fewer food restrictions. However, amprenavir is limited by the large number of pills that have to be consumed in a day. Abacavir is tarnished by a relatively high incidence (almost 20%) of hypersensitivity.

BACK

|About Us| |Guest Book| |Contact Us|

©Readiprintworld.com, 2000